HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pei Liu Selected Research

beta-tricalcium phosphate

5/2021Retraction Note: High failure rate after Beta-tricalcium phosphate grafting for the treatment of femoral head osteonecrosis: a retrospective analysis.
4/2020High failure rate after Beta-tricalcium phosphate grafting for the treatment of femoral head osteonecrosis: a retrospective analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pei Liu Research Topics

Disease

65Neoplasms (Cancer)
07/2022 - 09/2012
23Infections
12/2021 - 09/2002
19Inflammation (Inflammations)
09/2022 - 01/2013
13Acute Liver Failure (Fulminant Hepatic Failure)
08/2018 - 04/2005
11Neoplasm Metastasis (Metastasis)
07/2022 - 10/2015
11Dysmenorrhea (Menstrual Pain)
08/2016 - 01/2011
10Carcinogenesis
01/2021 - 11/2010
9Pain (Aches)
12/2022 - 11/2012
9Stomach Neoplasms (Stomach Cancer)
08/2022 - 01/2015
9Osteonecrosis (Kienbock's Disease)
05/2021 - 11/2019
8Breast Neoplasms (Breast Cancer)
08/2022 - 01/2016
8Glioma (Gliomas)
11/2021 - 11/2017
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2010
7Hypoxia (Hypoxemia)
01/2022 - 01/2018
7Lung Neoplasms (Lung Cancer)
11/2021 - 09/2012
7Hepatitis B
01/2020 - 09/2003
7Hepatorenal Syndrome
01/2012 - 10/2003
6Pneumonia (Pneumonitis)
09/2021 - 08/2015
6Carcinoma (Carcinomatosis)
01/2021 - 06/2012
6Necrosis
09/2010 - 11/2005
5Wounds and Injuries (Trauma)
05/2022 - 01/2019
5Sepsis (Septicemia)
05/2022 - 04/2021
5Hemorrhage
02/2022 - 08/2015
5Hepatocellular Carcinoma (Hepatoma)
01/2021 - 06/2011
5Melanoma (Melanoma, Malignant)
01/2021 - 10/2015
4Ischemic Stroke
07/2022 - 12/2016
4Ascites
05/2022 - 07/2017
4Brain Edema (Cerebral Edema)
01/2022 - 07/2011
4Bacterial Infections (Bacterial Infection)
01/2022 - 06/2016
4Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2021 - 01/2020
4Human Influenza (Influenza)
09/2021 - 05/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 09/2017
4Mental Disorders (Mental Disorder)
01/2021 - 12/2016
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019 - 06/2012
4Anemia
05/2019 - 01/2014
4Hypertension (High Blood Pressure)
01/2019 - 02/2014
4Prostatic Neoplasms (Prostate Cancer)
11/2018 - 06/2013
4Chronic Hepatitis B
01/2016 - 12/2006
3Fever (Fevers)
12/2022 - 01/2014
3Stroke (Strokes)
07/2022 - 01/2018
3Body Weight (Weight, Body)
01/2022 - 05/2017
3Brain Injuries (Brain Injury)
01/2022 - 01/2020
3Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2018
3Cognitive Dysfunction
01/2022 - 01/2021
3Thrombosis (Thrombus)
01/2022 - 10/2018
3COVID-19
12/2021 - 10/2020
3Fibrosis (Cirrhosis)
07/2021 - 07/2019
3Communicable Diseases (Infectious Diseases)
01/2021 - 03/2013
3Adenocarcinoma
01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
05/2022 - 04/2005
17VaccinesIBA
12/2022 - 07/2008
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2018 - 09/2003
14Pharmaceutical PreparationsIBA
01/2022 - 03/2014
13MicroRNAs (MicroRNA)IBA
01/2022 - 11/2010
10Biomarkers (Surrogate Marker)IBA
08/2022 - 12/2010
10DNA (Deoxyribonucleic Acid)IBA
09/2021 - 09/2002
81-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2022 - 01/2018
8Biological ProductsIBA
01/2020 - 11/2010
7LipopolysaccharidesIBA
11/2019 - 06/2007
7CytokinesIBA
06/2016 - 09/2003
6Messenger RNA (mRNA)IBA
06/2022 - 01/2012
6Oxygen (Dioxygen)IBA
01/2022 - 02/2014
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2020
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 02/2015
5Long Noncoding RNAIBA
01/2020 - 08/2018
5EnzymesIBA
01/2017 - 06/2002
4Interleukin-6 (Interleukin 6)IBA
06/2022 - 09/2003
4Cisplatin (Platino)FDA LinkGeneric
07/2021 - 06/2019
4GlucocorticoidsIBA
01/2021 - 11/2019
4C-Reactive ProteinIBA
10/2020 - 05/2010
4Phosphotransferases (Kinase)IBA
06/2020 - 11/2012
4LigandsIBA
01/2020 - 01/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
02/2017 - 09/2015
4xiang-fu-si-wuIBA
06/2015 - 01/2011
4GalactosamineIBA
07/2014 - 06/2007
4Tight Junction ProteinsIBA
09/2012 - 06/2007
3CateninsIBA
08/2022 - 03/2016
3Carrier Proteins (Binding Protein)IBA
06/2022 - 01/2009
3LipidsIBA
06/2022 - 04/2016
3Immune Checkpoint InhibitorsIBA
06/2022 - 01/2021
3salicylhydroxamic acid (SHAM)IBA
05/2022 - 04/2016
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
3AntigensIBA
01/2022 - 07/2008
3HydrogelsIBA
01/2022 - 10/2015
3Indicators and Reagents (Reagents)IBA
09/2021 - 10/2014
3CalciumIBA
01/2021 - 11/2012
3MethyltransferasesIBA
01/2021 - 06/2016
3Circular RNAIBA
01/2020 - 01/2018
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 06/2014

Therapy/Procedure

24Therapeutics
06/2022 - 10/2003
8Photothermal Therapy
01/2021 - 10/2014
7Radiotherapy
01/2022 - 11/2016
7Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 08/2014
6Photochemotherapy (Photodynamic Therapy)
09/2022 - 11/2018
6Immunotherapy
06/2022 - 06/2018
6Drug Therapy (Chemotherapy)
01/2021 - 11/2016
5Lasers (Laser)
11/2019 - 01/2018
4Oral Administration
11/2019 - 01/2013
3Chemoradiotherapy
07/2021 - 01/2020
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021 - 02/2019